Mechanism of Action: Metal Chelating Activity
✉ Email this page to a colleague
Drugs with Mechanism of Action: Metal Chelating Activity
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Navinta Llc | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211251-001 | Jan 16, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Msn | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211134-001 | May 22, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Zydus Pharms | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 211554-001 | Apr 26, 2019 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Watson Labs Teva | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 207567-001 | Feb 7, 2018 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Rising | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238-001 | Feb 20, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Rising | TRIENTINE HYDROCHLORIDE | trientine hydrochloride | CAPSULE;ORAL | 212238-002 | Sep 22, 2023 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
